The Daily Index — Friday, August 23, 2024 · TLDR Index

MISCELLANEOUS

TLDR

TLDR

THE TOP 100 GEN AI CONSUMER APPS

This post looks at which generative AI apps people are actually using. Creative tools are still drawing in consumers. ChatGPT is still the number one product on web and mobile by a large margin, but the competition is starting to heat up. New use cases are emerging, with some apps giving users beauty tips and others helping users uplevel their dating messages. Discord traffic is a leading indicator for apps that will climb the web and mobile ranks.

a16z.com · 8 min

TLDR

THE SILICON VALLEY CANON: ON THE PAIDEÍA OF THE AMERICAN TECH ELITE

Most Silicon Valley types make time to read books, book reviews, or listen to podcasts about books enough to fool others into thinking they have read a book. Books have an inordinate impact on the Silicon Valley mindspace. These books often have no obvious connection to software. They form a sort of vague tech canon. This article presents the list of books that form the Silicon Valley canon. These books cover the major ideas that are influential in tech.

scholars-stage.org · 16 min

TLDR

THE TOP PROGRAMMING LANGUAGES 2024

Python ranks as the most popular language, and it's pretty popular with employers too.

spectrum.ieee.org · 3 min

TLDR

IOS 18 ADDING DEFAULT APP CONTROLS FOR MESSAGING, PHONE CALLS, NAVIGATION, AND MORE IN THE EU

Apple is extending default app controls, making additional first-party apps deletable, and updating the browser choice screen in the EU.

9to5mac.com · 5 min

TLDR

CAN AI SCALING CONTINUE THROUGH 2030? (3 HOUR READ)

By 2030, it will very likely be possible to train models that exceed GPT-4 in scale to the same degree that GPT-4 exceeds GPT-2 in scale.

epochai.org

TLDR

AHEAD OF OCTOBER LAUNCH, JEFF BEZOS' BLUE ORIGIN ROCKET EXPLODES DURING TESTING

An upper portion of the rocket exploded during stress testing and a separate portion imploded.

futurism.com · 3 min

TLDR

THE COMPOUNDING LOOPHOLE

Compounding pharmacies, pharmacies that make some drugs on site, may be the answer to how the economy will handle the supply of expensive drugs in high demand like GLP-1 agonist drugs.

astralcodexten.com · 12 min